- Home
- ABSI vs SAR Comparison
ABSI vs SAR Comparison
Compare ABSI & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- SAR
- Stock Information
- Founded
- ABSI 2011
- SAR 2007
- Country
- ABSI United States
- SAR United States
- Employees
- ABSI N/A
- SAR N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- SAR Investment Managers
- Sector
- ABSI Health Care
- SAR Finance
- Exchange
- ABSI Nasdaq
- SAR Nasdaq
- Market Cap
- ABSI 353.8M
- SAR 337.6M
- IPO Year
- ABSI 2021
- SAR 2007
- Fundamental
- Price
- ABSI $2.75
- SAR $23.43
- Analyst Decision
- ABSI Strong Buy
- SAR Buy
- Analyst Count
- ABSI 5
- SAR 4
- Target Price
- ABSI $8.40
- SAR $25.08
- AVG Volume (30 Days)
- ABSI 2.5M
- SAR 88.4K
- Earning Date
- ABSI 05-13-2025
- SAR 05-07-2025
- Dividend Yield
- ABSI N/A
- SAR 14.13%
- EPS Growth
- ABSI N/A
- SAR 186.33
- EPS
- ABSI N/A
- SAR 2.02
- Revenue
- ABSI $4,534,000.00
- SAR $148,855,238.00
- Revenue This Year
- ABSI $158.58
- SAR $6.07
- Revenue Next Year
- ABSI $93.12
- SAR N/A
- P/E Ratio
- ABSI N/A
- SAR $11.64
- Revenue Growth
- ABSI N/A
- SAR 3.57
- 52 Week Low
- ABSI $2.01
- SAR $21.10
- 52 Week High
- ABSI $6.33
- SAR $26.49
- Technical
- Relative Strength Index (RSI)
- ABSI 42.92
- SAR 44.44
- Support Level
- ABSI $2.85
- SAR $22.22
- Resistance Level
- ABSI $2.94
- SAR $25.11
- Average True Range (ATR)
- ABSI 0.19
- SAR 0.56
- MACD
- ABSI -0.03
- SAR -0.05
- Stochastic Oscillator
- ABSI 14.13
- SAR 37.54
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About SAR Saratoga Investment Corp New
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.